Elizabeth A. Stewart

Elizabeth A. Stewart

Auto-generated profile, based on publicly available information

Elizabeth A. Stewart

Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in The Lancet
Verified
Journal Article
Closed access
ESElizabeth A Stewart
Elizabeth A Stewart

23 June 2016 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
ESElizabeth A. Stewart
Elizabeth A. Stewart
SLShannon K. Laughlin-Tommaso
Shannon K. Laughlin-Tommaso
WCWilliam H. Catherino
William H. Catherino
SLSujata Lalitkumar
Sujata Lalitkumar
DGDevashana Gupta
Devashana Gupta
BVBeverley Vollenhoven
Beverley Vollenhoven

1 March 2003 in Radiology
Verified
Journal Article
Closed access
CTClare M. C. Tempany
Clare M. C. Tempany
ESElizabeth A. Stewart
Elizabeth A. Stewart
NMNathan McDannold
Nathan McDannold
BQBradley J. Quade
Bradley J. Quade
FJFerenc A. Jolesz
Ferenc A. Jolesz
KHKullervo Hynynen
Kullervo Hynynen
The feasibility and safety of magnetic resonance (MR) imaging-guided focused ultrasound surgery for uterine leiomyomas is reported. Sequential sonications were delivered to nine targets. Temperature-sensitive phase-difference MR imaging monitored the location of the focus and measured tissue temperature elevations, ensuring therapeutic dose. MR images and hysterectomy specimens were evaluated. Six leiomyomas received full therapeutic doses, and 98.5% of the sonications were visualized. MR thermometry was successful in all sonications and cases. Focal necrotic lesions were seen in all cases at MR, and five were pathologically confirmed. MR imaging-guided focused ultrasound causes thermocoagulation and necrosis in uterine leiomyomas and is feasible and safe, without serious consequences.

10 June 2005 in Science
Verified
Journal Article
Closed access
PDF file
CWCheryl Lyn Walker
Cheryl Lyn Walker
ESElizabeth A. Stewart
Elizabeth A. Stewart
Uterine fibroids (leiomyomas) have historically been viewed as important chiefly as the major indication for hysterectomy. As new therapies are developed, the heterogeneity of this disease becomes therapeutically relevant. An awareness of the role of genetics, the extracellular matrix, and hormones in tumor etiology is key to understanding this disease.

23 April 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
ESElizabeth A Stewart
Elizabeth A Stewart
Fibroids, which are common in women of reproductive age, may cause heavy menstrual bleeding and symptoms related to leiomyoma bulk. Hysterectomy is an effective treatment, but many uterine-sparing options are available and should be discussed with patients.

1 January 2006 in Fertility and Sterility
Verified
Journal Article
Closed access
ESElizabeth A. Stewart
Elizabeth A. Stewart
JRJaron Rabinovici
Jaron Rabinovici
CTClare M.C. Tempany
Clare M.C. Tempany
YIYael Inbar
Yael Inbar
LRLeslie Regan
Leslie Regan
WGWladyslaw M. Gedroye
Wladyslaw M. Gedroye